1. |
Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections [J].Nat Clin Pract Gastroenterol Hepatol, 2008, 5(6): 321-331.
|
2. |
Zullo A, Gatta L, De Francesco V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer:a prospective controlled study[J].Aliment pharmacol Ther, 2005, 21(12): 1419-1424.
|
3. |
Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children:a randomized trial[J]. Gastroenterology, 2005, 129(5): 1414-1419.
|
4. |
Bago P, Vcer A, Tomic M, et al. High eradication rate of H.pylori with moxifloxacin-based treatment:a randomized controlled trial[J].Wien Klin Wochenschr, 2007, 119(11-12): 372-378.
|
5. |
De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori[J]. Ann Inter Med, 2006, 144(2): 94-100.
|
6. |
De Rossi E, Aínsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance:an unresolved question[J]. FEMS Microbiol Rev, 2006, 30(1):36-52.
|
7. |
Zechini B, Versace I. Inhibitiors of multidrug resistant efflux systems in bacteria[J]. Recent Pat Antiinfect Drug Discov, 2009, 4(1): 37-50.
|
8. |
Lomovskaya O, Bostian KA. Practical applications and feasibility of efflux pump inhibitors in the clinic-A vision for applied use[J]. Biochen Pharmacol, 2006, 71(7): 910-918.
|
9. |
Hong EJ, Park DI, Oh SJ, et al. Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors[J].Korean J Gastroenterol, 2008, 52(2): 80-85.
|
10. |
Aeschlimann JR, Dresser LD, Kaatz GW, et al. Effects of NorA in-hibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin,and norfloxacin in genetically related strains of staphylococcus aurens[J]. Antimicrob Agents Chemother, 1999, 43(2): 335-340.
|